Impact of switching from zidovudine/lamivudine to tenofovir/emtricitabine on lipoatrophy: The RECOMB study

E. Ribera, M. Larrousse, A. Curran, E. Negredo, B. Clotet, V. Estrada, J. Sanz, J. Berenguer, R. Rubio, F. Pulido, P. Ferrer, Ml Alvarez, S. Arterburn, E. Martínez

Research output: Contribution to journalArticleResearchpeer-review

12 Citations (Scopus)

Fingerprint Dive into the research topics of 'Impact of switching from zidovudine/lamivudine to tenofovir/emtricitabine on lipoatrophy: The RECOMB study'. Together they form a unique fingerprint.

Medicine & Life Sciences